[1] ARSLAN E,DEMIR S C,OZSURMELI M,et al.Perinatal outcomes and survival predictors of severe red-cell alloimmunization treated by intrauterine transfusion[J].J Obstet Gynaecol Res,2021,47(8):2632-2640. [2] URUTHERAKUMAR V,WELSH A,HENRY A.Short-term outcomes following intrauterine transfusions for fetal anaemia:a retrospective cohort study[J]. Aust N Z J Obstet Gynaecol,2020,60(5):738-745. [3] 孙笑,孙瑜,杨慧霞. 母胎Rh阴性血型不合的孕期监测与处理[J]. 中华围产医学杂志,2016,19(6):406-411. [4] SOCIETY for Maternal-Fetal Medicine (SMFM) Electronic address:pubs@smfm org,MARI G,NORTON M E,et al. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8:the fetus at risk for Anemia— diagnosis and management[J]. Am J Obstet Gynecol,2015,212(6):697-710. [5] NAKAYAMA A,OSHIRO M,YAMADA Y,et al.Prognostic factors of Hydrops fetalis with pleural effusion[J]. Pediatr Int,2017,59(10):1053-1057. [6] 魏瑗,赵扬玉. 胎儿宫内输血术及其并发症[J]. 实用妇产科杂志,2013,29(5):333-335. [7] 李偲,黄林环,罗艳敏,等. 宫内输血治疗红细胞同种免疫性胎儿溶血病的回顾性研究[J]. 中华围产医学杂志,2019,22(5):289-295. [8] BIRCHENALL K A,ILLANES S E,LOPEZ F,et al.Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion:a service evaluation[J]. Blood Transfus,2013,11(4):548-552. [9] 战军,邢爱耘. 多普勒超声测量胎儿大脑中动脉血流在高危妊娠中的研究进展[J]. 中华妇幼临床医学杂志(电子版),2012,8(2):220-223. [10] 杨芳,徐彩玲. 胎儿水肿病因学分析及诊治进展[J]. 中华产科急救电子杂志,2018,7(1):24-29. [11] LINDENBURG I T M,VAN Kamp I L,VAN Zwet E W,et al. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation[J]. BJOG Int J Obstet Gynaecol,2013,120(7):847-852. [12] VAN KAMP I L,KLUMPER F J,BAKKUM R S,et al. The severity of immune fetal Hydrops is predictive of fetal outcome after intrauterine treatment[J]. Am J Obstet Gynecol,2001,185(3):668-673. [13] 熊盈,吴菁,赵馨,等. 3例不明原因贫血胎儿宫内输血治疗疗效分析[J]. 中国产前诊断杂志(电子版),2019,11(3):6-9. [14] LINDENBURG I T M,VAN KAMP I L,OEPKES D. Intrauterine blood transfusion:current indications and associated risks[J]. Fetal Diagn Ther,2014,36(4):263-271. |